Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06374394
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-04-16
Brief Title:
A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus RSV When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline